94 results on '"Ferrari, S. L."'
Search Results
2. Improved hypothesis testing in a general multivariate elliptical model
3. A comparative review of generalizations of the Gumbel extreme value distribution with an application to wind speed data
4. Ischemic stroke is associated with reduced sclerostin expression in human atherosclerotic plaques
5. Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure
6. Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates
7. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club
8. Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women
9. Leptin and the sympathetic connection of fat to bone
10. Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk
11. Mice Lacking β-Adrenergic Receptors Have Increased Bone Mass but Are Not Protected from Deleterious Skeletal Effects of Ovariectomy
12. Contribution of Gender-Specific Genetic Factors to Osteoporosis Risk
13. Inhibition of IL-15 signaling induces a positive bone remodeling balance and high bone mass in intact and estrogen-deficient mice: 37
14. Bone Response to Intermittent Parathyroid Hormone Is Altered in Mice Null for β-Arrestin2
15. Two Promoter Polymorphisms Regulating Interleukin-6 Gene Expression Are Associated with Circulating Levels of C-Reactive Protein and Markers of Bone Resorption in Postmenopausal Women
16. A Functional Polymorphic Variant in the Interleukin-6 Gene Promoter Associated with Low Bone Resorption in Postmenopausal Women
17. Vitamin D receptor genotypes and bone mineral density
18. Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure
19. MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus
20. Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus.
21. -Arrestin-Biased Parathyroid Hormone Ligands: A New Approach to the Development of Agents that Stimulate Bone Formation
22. Mice Lacking β-Adrenergic Receptors Have Increased Bone Mass but Are Not Protected from Deleterious Skeletal Effects of Ovariectomy
23. Leptin and the sympathetic connection of fat to bone
24. Cellular Distribution of Constitutively Active Mutant Parathyroid Hormone (PTH)/PTH-Related Protein Receptors and Regulation of Cyclic Adenosine 3',5'-Monophosphate Signaling by -Arrestin2
25. The interaction between clarithromycin and cyclosporine in kidney transplant recipients
26. Do Dietary Calcium and Age Explain the Controversy Surrounding the Relationship Between Bone Mineral Density and Vitamin D Receptor Gene Polymorphisms?
27. THE INTERACTION BETWEEN CLARITHROMYCIN AND CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS
28. Parathyroid hormone-related protein production by primary cultures of mammary epithelial cells
29. Osteoporosis, vitamin D receptor gene polymorphisms and response to diet.
30. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy.
31. A note on Bartlett-type correction for the first few moments of test statistics
32. Second- and third-order bias reduction for one-parameter family models
33. Improved score tests for one-parameter exponential family models
34. Corrected score tests for exponential family nonlinear models
35. Bone microarchitecture, density, and geometry predict incident fracture independently of DXA BMD in older women and men: The Bone Microarchitecture International Consortium (BoMIC)
36. Role for N-cadherin in the development of the differentiated osteoblastic phenotype
37. Correction to: Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women.
38. Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk.
39. Diagnosis and management of bone fragility in diabetes: an emerging challenge.
40. Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women.
41. Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy.
42. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
43. Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells.
44. LRP5 gene polymorphisms and idiopathic osteoporosis in men.
45. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
46. Osteoporosis, genetics and hormones.
47. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3',5'-monophosphate signaling by beta-arrestin2.
48. A role for N-cadherin in the development of the differentiated osteoblastic phenotype.
49. Osteoporosis in patients undergoing lung transplantation.
50. Effects of epidermal growth factor on parathyroid hormone-related protein production by mammary epithelial cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.